Head-to-head · Cost-Efficiency Index
TeleDocs360 vs Fierce Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
TeleDocs360
Shoppers who want dose-tier pricing spelled out clearly upfront rather than a vague 'starting at' hook.
Visit TeleDocs360Fierce Health
Shoppers specifically seeking a below-standard 'microdose' GLP-1 protocol at a discounted entry price.
Visit Fierce HealthThe verdict
TeleDocs360 and Fierce Health tie on the Cost-Efficiency Index at 55/100, so neither wins outright on the numbers. For most shoppers we'd start with TeleDocs360 (ranked #347, a hair above #351) — Shoppers who want dose-tier pricing spelled out clearly upfront rather than a vague 'starting at' hook. But Fierce Health is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs TeleDocs360.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | TeleDocs360 | Fierce Health |
|---|---|---|
| Cost-Efficiency Index | 55/100 | 55/100 |
| Semaglutide / mo | $299/mo (compounded) | Not disclosed |
| Tirzepatide / mo | $399/mo (compounded) | Not disclosed |
| Semaglutide / yr (modeled) | $3,588 | — |
| Tirzepatide / yr (modeled) | $4,788 | — |
| Coverage | Coverage not published | 30 states |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #347 | #351 |
TeleDocs360
55/100Where the value is
- Rare in this category: pricing exceptions for higher doses are stated plainly, not buried
- One flat all-inclusive price (doctor, medication, shipping)
- Physician network (Impact Health) named
The tradeoffs
- No individual medical director named, only the physician network
- Compounding pharmacy partner not disclosed
Fierce Health
55/100Where the value is
- Semaglutide is currently listed at a steep markdown ($197 vs. a stated $591 regular price) if the discount holds at checkout
- Sells both semaglutide and tirzepatide with clearly separated pricing rather than bundling them
- Discloses the standard compounding/FDA disclaimer plainly in the footer
The tradeoffs
- The $591 'regular price' next to a $197 'sale price' is a large, unexplained gap — no page discloses how long the discount lasts or what the price reverts to
- No mg dose amount is disclosed for either 'microdose' product on any page reached
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.